Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Decaprenylphosphoryl-beta-D-ribose 2'-epimerase (None)
- Target
- None
- Molecular classification
- Enzyme, Oxidoreductase, Flavoenzyme, Reductase
01
Overview
Decaprenylphosphoryl-beta-D-ribose 2'-epimerase (DprE1/DprE2 complex) is an essential enzyme in mycobacteria, including Mycobacterium tuberculosis, responsible for synthesizing decaprenylphosphoryl arabinose (DPA), a crucial precursor for cell wall components. It catalyzes the epimerization of decaprenylphosphoryl-beta-D-ribose (DPR) to DPA. As it's absent in humans, it's a validated drug target for anti-tubercular agents. Inhibition disrupts cell wall biosynthesis, leading to bacterial death.
- Other names
- DprE1Rv3790DprE2Rv3791
02
Mechanism of action
Inhibition of cell wall biosynthesis via covalent modification of DprE1
03
Biological functions
Cell wall biosynthesisArabinose metabolismDecaprenylphosphoryl arabinose (DPA) synthesis
04
Disease associations
InfectionTuberculosis
05
Interacting drugs
Benzothiazinones (BTZs)
1 more in the full profile.
Beyond the preview
Go deeper on Decaprenylphosphoryl-beta-D-ribose 2'-epimerase (None).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Decaprenylphosphoryl-beta-D-ribose 2'-epimerase (None).